• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

狗红细胞抗原 1 同种免疫——接受弱狗红细胞抗原 1+血液输注的狗。

Alloimmunization of a dog erythrocyte antigen 1- dog transfused with weakly dog erythrocyte antigen 1+ blood.

机构信息

Dianov Laboratories, Limonest, France.

VetAgro Sup - SIAMU, Marcy l'Etoile, France.

出版信息

J Vet Intern Med. 2019 Sep;33(5):2037-2045. doi: 10.1111/jvim.15565. Epub 2019 Jul 30.

DOI:10.1111/jvim.15565
PMID:31361062
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6766507/
Abstract

BACKGROUND

Acute hemolytic transfusion reactions because of dog erythrocyte antigen (DEA) 1 sensitization after mismatched transfusions are serious complications. Dog erythrocyte antigen 1 expression varies from negative to weakly to strongly positive.

OBJECTIVES

To assess alloimmunization after transfusion of weakly DEA 1+ blood to a DEA 1- dog.

ANIMALS

One DEA 1- recipient and 1 weakly DEA 1+ donor, and 106 control dogs.

METHODS

Long-term follow-up study. Matched for DEA 3, 4, 5, and 7, Dal, and Kai 1 and 2, weakly DEA 1+ donor packed red blood cells (RBCs) were transfused 3 times (0.45 mL/kg at Day 0, 16, and 37) to a DEA 1- recipient. Alloantibodies against RBCs from donor and 106 controls were determined in recipient's plasma samples using a commercial antiglobulin-enhanced immunochromatographic strip and gel tube crossmatches. Alloantibody titers were determined.

RESULTS

The DEA 1- recipient was sensitized after 16 days to ≥1657 days after transfusion to weakly DEA 1+ and otherwise matched RBCs. Strong to moderate crossmatch incompatibilities were observed between recipient's plasma and all 61 DEA 1+ crossmatched controls. Moderate to weak incompatibilities were also observed to DEA 1- controls. Anti-DEA 1 and other alloantibodies were detected over the 4.5 year observation period.

CONCLUSIONS AND CLINICAL IMPORTANCE

Blood from a weakly DEA 1+ donor induces a strong and durable alloimmunization in a DEA 1- recipient dog. Additional alloantibodies developed against yet to be defined RBC antigens. Those results support the recommendation of typing dogs against DEA 1, considering weakly DEA 1+ as immunogenic, and crossmatching all previously transfused dogs.

摘要

背景

由于配血不合导致的犬红细胞抗原(DEA)1 致敏后发生急性溶血性输血反应是一种严重的并发症。犬红细胞抗原 1 的表达从阴性到弱阳性到强阳性不等。

目的

评估将弱 DEA 1+血液输给 DEA 1-犬后的同种免疫情况。

动物

一只 DEA 1-受者和一只弱 DEA 1+供者,以及 106 只对照犬。

方法

长期随访研究。用 DEA 3、4、5、7、Dal 和 Kai 1 和 2 进行配型,将弱 DEA 1+供者的浓缩红细胞(RBC)分 3 次(0.45 mL/kg,分别在第 0、16 和 37 天)输给一只 DEA 1-受者。用商业抗球蛋白增强免疫层析条和凝胶试管交叉配血法检测受者血浆样本中针对供者和 106 只对照犬 RBC 的同种抗体。测定同种抗体效价。

结果

在输注弱 DEA 1+且其他方面均匹配的 RBC 后 16 天,DEA 1-受者致敏,致敏后 1657 天以上仍存在致敏。受者血浆与 61 名强至中度交叉配血不合的 DEA 1+交叉配血对照者之间存在强至中度交叉配血不合,与 DEA 1-对照者之间也存在中度至弱的交叉配血不合。在 4.5 年的观察期间,检测到抗-DEA 1 和其他同种抗体。

结论和临床意义

来自弱 DEA 1+供者的血液在 DEA 1-受者犬中引起强烈且持久的同种免疫。针对尚未确定的 RBC 抗原产生了额外的同种抗体。这些结果支持对犬进行 DEA 1 定型的建议,将弱 DEA 1+视为免疫原性,并对所有以前输注过的犬进行交叉配血。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b5/6766507/c78f8bd0771d/JVIM-33-2037-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b5/6766507/a8c851ee5c4d/JVIM-33-2037-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b5/6766507/00965e176d98/JVIM-33-2037-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b5/6766507/ee5d79fbc529/JVIM-33-2037-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b5/6766507/73ae3aa9881f/JVIM-33-2037-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b5/6766507/3571dad7a48f/JVIM-33-2037-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b5/6766507/c78f8bd0771d/JVIM-33-2037-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b5/6766507/a8c851ee5c4d/JVIM-33-2037-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b5/6766507/00965e176d98/JVIM-33-2037-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b5/6766507/ee5d79fbc529/JVIM-33-2037-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b5/6766507/73ae3aa9881f/JVIM-33-2037-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b5/6766507/3571dad7a48f/JVIM-33-2037-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f8b5/6766507/c78f8bd0771d/JVIM-33-2037-g006.jpg

相似文献

1
Alloimmunization of a dog erythrocyte antigen 1- dog transfused with weakly dog erythrocyte antigen 1+ blood.狗红细胞抗原 1 同种免疫——接受弱狗红细胞抗原 1+血液输注的狗。
J Vet Intern Med. 2019 Sep;33(5):2037-2045. doi: 10.1111/jvim.15565. Epub 2019 Jul 30.
2
Pre- and Post-Transfusion Alloimmunization in Dogs Characterized by 2 Antiglobulin-Enhanced Cross-match Tests.通过两次抗球蛋白增强交叉配血试验对犬输血前后同种免疫的特征分析
J Vet Intern Med. 2017 Sep;31(5):1420-1429. doi: 10.1111/jvim.14801. Epub 2017 Aug 14.
3
An acute hemolytic transfusion reaction caused by dog erythrocyte antigen 1.1 incompatibility in a previously sensitized dog.一只先前已致敏的犬因犬红细胞抗原1.1不相容性引发急性溶血性输血反应。
J Am Vet Med Assoc. 1995 May 1;206(9):1358-62.
4
Hemolytic transfusion reactions in a dog with an alloantibody to a common antigen.一只对常见抗原产生同种抗体的犬发生的溶血性输血反应。
J Vet Intern Med. 1995 Jul-Aug;9(4):277-9. doi: 10.1111/j.1939-1676.1995.tb01080.x.
5
Frequency of dog erythrocyte antigen 1.1 in 4 breeds native to different areas in Turkey.土耳其不同地区原产的4个犬种中犬红细胞抗原1.1的频率
Vet Clin Pathol. 2011 Dec;40(4):518-523. doi: 10.1111/j.1939-165X.2011.00370.x.
6
Prevalence of naturally occurring antibodies against dog erythrocyte antigen 7 in a population of dog erythrocyte antigen 7-negative dogs from Spain and Italy.西班牙和意大利一群犬红细胞抗原7阴性犬中天然存在的抗犬红细胞抗原7抗体的流行情况。
Am J Vet Res. 2016 Aug;77(8):877-81. doi: 10.2460/ajvr.77.8.877.
7
Survey of Two New (Kai 1 and Kai 2) and Other Blood Groups in Dogs of North America.北美犬类中两种新血型(Kai 1和Kai 2)及其他血型的调查。
J Vet Intern Med. 2016 Sep;30(5):1642-1647. doi: 10.1111/jvim.14572. Epub 2016 Sep 14.
8
The dog erythrocyte antigen 1 blood group in nondomesticated canids and compatibility testing between domestic dog and nondomesticated canid blood.犬非驯化动物红细胞抗原 1 血型和犬与非驯化犬属动物血液的相容性测试。
J Vet Intern Med. 2020 Nov;34(6):2365-2373. doi: 10.1111/jvim.15950. Epub 2020 Nov 3.
9
Activity, specificity, and titer of naturally occurring canine anti-DEA 7 antibodies.天然存在的犬抗DEA 7抗体的活性、特异性和效价。
J Vet Diagn Invest. 2016 Nov;28(6):705-708. doi: 10.1177/1040638716668626. Epub 2016 Sep 16.
10
Characterization of Anti- Dal Alloantibodies Following Sensitization of Two Dal-Negative Dogs.两只Dal阴性犬致敏后抗Dal同种抗体的特性分析
Vet Pathol. 2018 Jan;55(1):108-115. doi: 10.1177/0300985816688746. Epub 2017 Jan 27.

引用本文的文献

1
Evaluation of post-transfusion RBC alloimmunization in dogs using a gel-column crossmatch with and without anti-canine globulin enhancement.使用带有和不带有抗犬球蛋白增强剂的凝胶柱交叉配血法评估犬输血后红细胞同种免疫情况。
J Vet Diagn Invest. 2024 Mar;36(2):213-221. doi: 10.1177/10406387231222895. Epub 2024 Jan 11.
2
Validation of a cage-side agglutination card for Dal blood typing in dogs.犬只 Dal 血型鉴定卡的笼边凝集效价验证。
J Vet Intern Med. 2023 Mar;37(2):503-509. doi: 10.1111/jvim.16646. Epub 2023 Mar 2.
3
Crossmatch: Alloimmunization versus unspecific agglutination reactions?

本文引用的文献

1
Detection of naturally occurring alloantibody by an in-clinic antiglobulin-enhanced and standard crossmatch gel column test in non-transfused domestic shorthair cats.通过临床抗球蛋白增强和标准交叉配血凝胶柱试验检测未输血的家养短毛猫体内自然产生的同种抗体。
J Vet Intern Med. 2019 Mar;33(2):588-595. doi: 10.1111/jvim.15381. Epub 2018 Dec 17.
2
Pre- and Post-Transfusion Alloimmunization in Dogs Characterized by 2 Antiglobulin-Enhanced Cross-match Tests.通过两次抗球蛋白增强交叉配血试验对犬输血前后同种免疫的特征分析
J Vet Intern Med. 2017 Sep;31(5):1420-1429. doi: 10.1111/jvim.14801. Epub 2017 Aug 14.
3
Kai 1 and Kai 2: Characterization of these dog erythrocyte antigens by monoclonal antibodies.
交叉配血:同种免疫与非特异性凝集反应?
J Vet Intern Med. 2023 Jan;37(1):8-9. doi: 10.1111/jvim.16626. Epub 2023 Jan 4.
4
Alloimmunization in dogs after transfusion: A serial cross-match study.犬输血后同种免疫:系列交叉配血研究。
J Vet Intern Med. 2022 Sep;36(5):1660-1668. doi: 10.1111/jvim.16521. Epub 2022 Aug 19.
5
The dog erythrocyte antigen 1 blood group in nondomesticated canids and compatibility testing between domestic dog and nondomesticated canid blood.犬非驯化动物红细胞抗原 1 血型和犬与非驯化犬属动物血液的相容性测试。
J Vet Intern Med. 2020 Nov;34(6):2365-2373. doi: 10.1111/jvim.15950. Epub 2020 Nov 3.
6
Survey of Blood Groups , and in Different Canine Breeds From a Diagnostic Laboratory in Germany.德国一家诊断实验室对不同犬种血型的调查
Front Vet Sci. 2020 Feb 28;7:85. doi: 10.3389/fvets.2020.00085. eCollection 2020.
Kai 1和Kai 2:用单克隆抗体对这些犬红细胞抗原进行特性鉴定。
PLoS One. 2017 Jun 29;12(6):e0179932. doi: 10.1371/journal.pone.0179932. eCollection 2017.
4
Activity, specificity, and titer of naturally occurring canine anti-DEA 7 antibodies.天然存在的犬抗DEA 7抗体的活性、特异性和效价。
J Vet Diagn Invest. 2016 Nov;28(6):705-708. doi: 10.1177/1040638716668626. Epub 2016 Sep 16.
5
Survey of Two New (Kai 1 and Kai 2) and Other Blood Groups in Dogs of North America.北美犬类中两种新血型(Kai 1和Kai 2)及其他血型的调查。
J Vet Intern Med. 2016 Sep;30(5):1642-1647. doi: 10.1111/jvim.14572. Epub 2016 Sep 14.
6
Prevalence of naturally occurring antibodies against dog erythrocyte antigen 7 in a population of dog erythrocyte antigen 7-negative dogs from Spain and Italy.西班牙和意大利一群犬红细胞抗原7阴性犬中天然存在的抗犬红细胞抗原7抗体的流行情况。
Am J Vet Res. 2016 Aug;77(8):877-81. doi: 10.2460/ajvr.77.8.877.
7
Detection rate of blood group alloimmunization based on real-world testing practices and kinetics of antibody induction and evanescence.基于实际检测实践以及抗体诱导和消失动力学的血型同种免疫检测率
Transfusion. 2016 Nov;56(11):2662-2667. doi: 10.1111/trf.13704. Epub 2016 Jul 9.
8
Dog erythrocyte antigen 1: mode of inheritance and initial characterization.犬红细胞抗原1:遗传模式及初步特征
Vet Clin Pathol. 2015 Sep;44(3):369-79. doi: 10.1111/vcp.12284. Epub 2015 Aug 20.
9
DEA 1 expression on dog erythrocytes analyzed by immunochromatographic and flow cytometric techniques.通过免疫色谱和流式细胞术分析犬红细胞上的DEA 1表达。
J Vet Intern Med. 2014 Mar-Apr;28(2):592-8. doi: 10.1111/jvim.12321. Epub 2014 Feb 24.
10
Risk factors for transfusion-associated complications and nonsurvival in dogs receiving packed red blood cell transfusions: 211 cases (2008-2011).接受红细胞输注的犬发生输血相关并发症及非存活的危险因素:211例病例(2008 - 2011年)
J Am Vet Med Assoc. 2014 Feb 15;244(4):431-7. doi: 10.2460/javma.244.4.431.